QID 375925

Date Published: 2021-10-04

QID 375925: IBM Spectrum Protect Server Multiple Vulnerabilities (6446749)

IBM Spectrum Protect provides automated, centrally scheduled, policy-managed backup, archive, and space-management capabilities for file servers.

CVE-2020-4701: IBM DB2 for Linux, UNIX and Windows (includes DB2 Connect Server) 10.5, 11.1, and 11.5 is vulnerable to a buffer overflow, caused by improper bounds checking which could allow a local attacker to execute arbitrary code on the system with root privileges.
CVE-2020-4739: IBM Db2 for Linux, UNIX and Windows (includes Db2 Connect Server) 9.7, 10.1, 10.5, 11.1, and 11.5 could allow a local authenticated attacker to execute arbitrary code on the system, caused by DLL search order hijacking vulnerability in Microsoft Windows client.

Affected Versions:
IBM Spectrum Protect Server 8.1.0.000 - 8.1.11.xxx
IBM Spectrum Protect Server 7.1.0.000 - 7.1.12.xxx

QID Detection Logic(Authenticated):
This checks for vulnerable versions of IBM Spectrum Protect.

Successful exploitation it allows an unauthenticated attacker to cause high confidentiality, integrity and availability impact.

CVSS V3 rated as High - 7.8 severity.

CVSS V2 rated as High - 7.2 severity.

Solution

Vendor has released updated version to address this issue. Refer to 6446749 for details.

Vendor References

6446749 - www.ibm.com/support/pages/node/6446749

CVEs related to QID 375925

CVE-2020-4701 | CVE-2020-4739 |

Software Advisories

Advisory ID	Software	Component	Link
6446749			www.ibm.com/support/pages/node/6446749

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].